KẾT QUẢ PHẪU THUẬT KẾT HỢP ĐỐT SÓNG CAO TẦN ĐIỀU TRỊ UNG THƯ BIỂU MÔ TẾ BÀO GAN TẠI BỆNH VIỆN HỮU NGHỊ VIỆT ĐỨC

Abstract

Objectives: Describe the clinical and paraclinical characteristics of hepatocellular carcinoma patients treated with surgery combined with radiofrequency ablation from January 2018 to December 2022. Evaluate the early results of surgery combined with radiofrequency ablation in the above group of patients. Method: Retrospective descriptive study on 40 patients diagnosed with hepatocellular carcinoma who underwent surgery combined with intraoperative radiofrequency ablation at Viet Duc University Hospital from January 2018 to December 2022. Results and discussion: The average age was 58.4 ± 9.6 years (37-74 years). Men account for 80%. Most patients are infected with hepatitis B and hepatitis C; Child-Pugh A level cirrhosis. Over 50% of patients have a preoperative αFP threshold below the diagnostic threshold. Most tumors are located in one subsegment of the liver, the majority of tumors are located in the right liver. The rate of patients requiring preoperative biopsy is shallow. The average surgery time for 40 patients was 190 minutes. The surgery time in the study groups did not differ much. There are 40% of patients who do not have liver resection but only radiofrequency ablation. Among patients with liver resection, the proportion of small liver resections accounts for the majority. The rate of complications during surgery was low (8%), all of which were successfully treated during surgery. After surgery, there were only mild complications (accounting for 20%), all successfully treated medically. The average hospital stay was 9.5 days. Conclusions: Surgery combined with radiofrequency ablation in surgery to treat hepatocellular carcinoma is currently a safe and highly effective method in treating hepatocellular carcinomas.